Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00051324 · ClinicalTrials.gov registry record
Neurobiological Predictors of Huntington's Disease (PREDICT-HD)
A clinical trial of Huntington Disease, sponsored by Jordan Schultz.
- Active
- Registry status
- 1,700
- Enrollment target
- 1
- Study location
NCT00051324 is a study of Huntington Disease that is active but no longer recruiting, run by Jordan Schultz. The registered enrollment target is 1,700 participants, above the 587-participant average among 35 other Huntington Disease trials with a reported enrollment target (190% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00051324, a study of Huntington Disease, is active but no longer recruiting, sponsored by Jordan Schultz.
- ACTIVE NOT RECRUITING
- Registry status
- 1,700 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to study early brain and behavioral changes in people who have the gene expansion for Huntington's disease, but are currently healthy and have no symptoms.
Conditions Studied
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,700 participants |
| Start Date | 2002-08 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00051324
The ClinicalTrials.gov registry entry for NCT00051324 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,700 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 587-participant average among 35 other Huntington Disease trials with a reported enrollment target (190% higher). The listed sponsor is Jordan Schultz, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Huntington Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00051324 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT00051324 about?
NCT00051324 is a clinical study titled "Neurobiological Predictors of Huntington's Disease (PREDICT-HD)". The purpose of this trial is to study early brain and behavioral changes in people who have the gene expansion for Huntington's disease, but are currently healthy and have no symptoms.
What is the current status of trial NCT00051324?
This trial is currently active not recruiting. The enrollment target is 1,700 participants. The study started on 2002-08. Estimated completion is 2025-06-30.
What conditions does trial NCT00051324 study?
This clinical trial studies the following conditions: Huntington Disease.
Who is sponsoring clinical trial NCT00051324?
This trial is sponsored by Jordan Schultz, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00051324 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Huntington Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Longitudinal Endpoint Assessment of Disease Burden in HD
RECRUITING
-
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers
RECRUITING
-
Extracellular Vesicles for HD
RECRUITING
-
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
RECRUITING · Phase 3
-
A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.